Home › Lymphoma › Washington › Seattle
Pag-aaral pangklinika para sa Lymphoma sa Seattle, WA
Isang pag-aaral para sa Lymphoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Seattle. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma
Nagre-recruitPhase 2
- Fred Hutchinson Cancer Center, Seattle
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
Nagre-recruitPhase 2
- Fred Hutchinson Cancer Center, Seattle
Collection of Tissue Samples for Cancer Research
Nagre-recruitObservasyonal na pag-aaral
- Fred Hutchinson, Seattle
Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- Seattle Children s Hospital, Seattle
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
Nagre-recruitPhase 1/2
- Swedish Cancer Institute, Seattle
- Fred Hutchinson Cancer Center, Seattle
A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies
Nagre-recruitPhase 1
- Fred Hutch Cancer Center, Seattle
DALY II USA/ MB-CART2019.1 for DLBCL
Nagre-recruitPhase 2
- Fred Hutchinson Cancer Center, Seattle
A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas
Nagre-recruitPhase 1/2
- Dren Investigational Site, Seattle
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
Nagre-recruitObservasyonal na pag-aaral
- Seattle Children's Hospital, Seattle
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
Nagre-recruitPhase 1/2
- University of Washington Medical Center, Seattle
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
Nagre-recruitPhase 2
- Fred Hutchinson Cancer Center, Seattle
A Randomized Phase II Study Of Bruton Tyrosine Kinase Inhibitor With Or Without Venetoclax In Veterans With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Nagre-recruitPhase 2
- VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle
Pag-aaral para sa Lymphoma sa ibang lungsod
- Houston, TX34 pag-aaral
- Boston, MA33 pag-aaral
- New York City, NY33 pag-aaral
- Washington, DC23 pag-aaral
- Baldwin Park, CA21 pag-aaral
- Chicago, IL20 pag-aaral
- Durham, NC17 pag-aaral
- St. Louis, MO15 pag-aaral
- Philadelphia, PA15 pag-aaral
- Cleveland, OH14 pag-aaral
- Edison, NJ12 pag-aaral
- Atlanta, GA12 pag-aaral
Iba pang pag-aaral sa Seattle
- Non-Small Cell Lung Cancer53 pag-aaral
- Kanser (lahat ng uri)49 pag-aaral
- Kanser sa Prostate42 pag-aaral
- Acute Myeloid Leukemia40 pag-aaral
- Kanser sa Suso39 pag-aaral
- Metastatic Cancer39 pag-aaral
- Colorectal Cancer34 pag-aaral
- Kanser sa Baga33 pag-aaral
- Kanser sa Ovary30 pag-aaral
- Multiple Myeloma22 pag-aaral
- Myelodysplastic Syndromes21 pag-aaral
- Acute Lymphoblastic Leukemia21 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.